PHI with Nephrogenic hypertension
How does this condition affect your private health insurance?
Nephrogener Hochdruck, or renovascular hypertension, is high blood pressure caused by impaired blood flow to the kidneys, most commonly due to narrowing (stenosis) of one or both renal arteries. This stenosis, often caused by atherosclerosis or fibromuscular dysplasia, reduces renal perfusion, activating the renin-angiotensin-aldosterone system (RAAS). This leads to systemic vasoconstriction and increased sodium and water retention, resulting in elevated blood pressure that can be severe and difficult to control. It can cause progressive kidney damage and increase the risk of cardiovascular events like heart attack and stroke if left untreated. Early diagnosis is crucial for effective management.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Gradual onset, often asymptomatic for months to years before significant symptoms or complications arise.
Duration of Illness (Lifetime)
Chronic, lifelong if untreated or not successfully corrected; potential for resolution with successful revascularization in some cases.
Cost of Treatment (Initial)
Moderate to high (diagnostic imaging, medication, specialist consultation).
Cost of Treatment (Lifetime)
High (chronic medication, regular monitoring, potential interventional procedures like angioplasty/stenting or surgery).
Mortality Rate
Increased risk of cardiovascular events (stroke, heart attack) and progressive kidney failure, contributing significantly to mortality if uncontrolled.
Risk of Secondary Damages
High (progressive kidney damage/failure, heart failure, stroke, aortic dissection risk, vision impairment).
Probability of Full Recovery
Moderate to high with early diagnosis and successful revascularization for amenable lesions; lower with advanced kidney damage or long-standing severe hypertension.
Underlying Disease Risk
High (atherosclerosis, fibromuscular dysplasia, diabetes mellitus, chronic kidney disease, other systemic vascular conditions).